Shanghai Sigma Audley SSA
GHK-Cu
Finnrick tested 8 samples of GHK-Cu from Shanghai Sigma Audley SSA between 4 Aug 2025 and 7 Nov 2025. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).
Finnrick Rating™
Shanghai Sigma Audley SSA
GHK-Cu
Tested 8 Samples
Last test 7 Nov 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other GHK-Cu tests from top-rated vendors:
All GHK-Cu tests from Shanghai Sigma Audley SSA
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
7 Nov 2025
First
4 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 7 Nov 2025 | View | 50mg | 55.14mg | +10.3% | 99.98% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab A | Public | |
| 29 Oct 2025 | View | 50mg | 40.8mg | -18.4% | 99.93% | Sacu5020250728f | No Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 9 Oct 2025 | View | 50mg | 47mg | -6.0% | 99.94% | (no batch ID) | No Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 25 Sep 2025 | View | 100mg | 82.7mg | -17.3% | 99.93% | SACU10020250728F | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 18 Sep 2025 | View | 50mg | 42mg | -16.0% | 99.92% | SACU5020250728F | No Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 14 Aug 2025 | View | 100mg | 100.4mg | +0.4% | 99.95% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab F | Public | |
| 12 Aug 2025 | View | 50mg | 53.2mg | +6.4% | 99.77% | (no batch ID) | No Label / Silver Crimp / Clear Teal Cap | Lab E | Public | |
| 4 Aug 2025 | View | 50mg | 51.1mg | +2.2% | 99.82% | 04-02-25 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |